Solid Biosciences LLC (SLDB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $763.42M
Last updated: Nov 17, 2026 at 11:05 AM ET
Solid Biosciences LLC (SLDB) Earnings: Report Dates and Results
Solid Biosciences LLC (SLDB) is expected to report earnings on Mar 4, 2027. In the quarter ended Sep 30, 2026, Solid Biosciences LLC reported EPS of -$0.36, above the -$0.37 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
SLDB has an expected report date of Mar 4, 2027.
Earnings History
Of the 36 quarters below that had an estimate, SLDB beat 16 and missed 20. The widest gap in the table came in the quarter ended Sep 30, 2022, when EPS landed 65.24% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.36 | -$0.37 | -$0.53 - -$0.34 | +2.70% | Beat | N/A | 14 | 8 up, 1 down | Nov 4, 2026 | N/A |
| Jun 30, 2026 | -$0.38 | -$0.43 | -$0.56 - -$0.36 | +11.63% | Beat | N/A | 12 | 2 up, 9 down | Aug 6, 2026 | N/A |
| Mar 31, 2026 | -$0.52 | -$0.44 | -$0.56 - -$0.35 | -17.89% | Miss | N/A | 12 | N/A | May 12, 2026 | N/A |
| Dec 31, 2025 | -$0.53 | -$0.52 | -$0.63 - -$0.45 | -1.92% | Miss | N/A | 12 | 0 up, 1 down | Mar 19, 2026 | N/A |
| Sep 30, 2025 | -$0.48 | -$0.44 | -$0.54 - -$0.38 | -9.09% | Miss | N/A | 11 | 8 up, 2 down | Nov 3, 2025 | N/A |
| Jun 30, 2025 | -$0.42 | -$0.49 | -$0.59 - -$0.42 | +14.29% | Beat | N/A | 11 | 5 up, 5 down | Aug 12, 2025 | N/A |
| Mar 31, 2025 | -$0.59 | -$0.53 | -$0.77 - -$0.39 | -11.32% | Miss | N/A | 10 | 5 up, 1 down | May 15, 2025 | N/A |
| Dec 31, 2024 | -$1.00 | -$0.78 | -$0.91 - -$0.48 | -27.84% | Miss | N/A | 9 | 1 up, 0 down | Mar 6, 2025 | $3.12M |
| Sep 30, 2024 | -$0.79 | -$0.66 | -$0.70 - -$0.63 | -19.70% | Miss | N/A | 9 | 0 up, 0 down | Nov 6, 2024 | N/A |
| Jun 30, 2024 | -$0.61 | -$0.66 | -$0.72 - -$0.61 | +7.58% | Beat | N/A | 8 | 0 up, 0 down | Aug 13, 2024 | N/A |
| Mar 31, 2024 | -$0.64 | -$0.60 | -$1.09 - -$0.52 | -6.67% | Miss | N/A | 8 | 0 up, 0 down | May 15, 2024 | N/A |
| Dec 31, 2023 | -$1.00 | -$0.99 | -$1.35 - -$0.54 | -1.01% | Miss | N/A | 5 | 0 up, 0 down | Mar 13, 2024 | $4.74M |
| Sep 30, 2023 | -$1.05 | -$1.20 | -$1.28 - -$1.05 | +12.50% | Beat | N/A | 5 | 0 up, 0 down | Nov 8, 2023 | N/A |
| Jun 30, 2023 | -$1.26 | -$1.41 | -$1.58 - -$1.41 | +10.64% | Beat | N/A | 4 | 0 up, 0 down | Aug 14, 2023 | N/A |
| Mar 31, 2023 | -$1.54 | -$1.25 | -$3.30 - -$1.23 | -23.20% | Miss | N/A | 4 | 0 up, 0 down | May 11, 2023 | N/A |
| Dec 31, 2022 | -$0.68 | -$1.65 | -$2.85 - -$0.56 | +58.79% | Beat | N/A | 4 | 0 up, 0 down | Mar 23, 2023 | $1.93M |
| Sep 30, 2022 | -$2.71 | -$1.64 | -$3.45 - -$1.50 | -65.24% | Miss | N/A | 5 | 1 up, 0 down | Nov 10, 2022 | N/A |
| Jun 30, 2022 | -$3.13 | -$2.92 | N/A | -7.19% | Miss | N/A | N/A | 0 up, 0 down | Aug 11, 2022 | $6.17M |
| Mar 31, 2022 | -$3.30 | -$2.78 | -$3.00 - -$2.55 | -18.70% | Miss | N/A | 5 | 0 up, 0 down | Apr 27, 2022 | N/A |
| Dec 31, 2021 | -$2.40 | -$2.91 | -$3.15 - -$2.55 | +17.53% | Beat | N/A | 5 | 0 up, 0 down | Mar 14, 2022 | $3.15M |
| Sep 30, 2021 | -$2.40 | -$2.99 | -$3.45 - -$2.55 | +19.73% | Beat | N/A | 7 | N/A | Nov 3, 2021 | $3.54M |
| Jun 30, 2021 | -$2.55 | -$2.83 | -$3.45 - -$2.25 | +9.89% | Beat | N/A | 6 | N/A | Aug 16, 2021 | $3.59M |
| Mar 31, 2021 | -$2.85 | -$4.85 | -$7.50 - -$3.00 | +41.24% | Beat | N/A | 5 | N/A | May 14, 2021 | $3.33M |
| Dec 31, 2020 | -$4.65 | -$5.09 | -$8.10 - -$3.15 | +8.64% | Beat | N/A | 5 | N/A | Mar 15, 2021 | $98.32M |
| Sep 30, 2020 | -$6.60 | -$5.47 | -$6.45 - -$4.20 | -20.66% | Miss | N/A | 5 | N/A | Nov 5, 2020 | N/A |
| Jun 30, 2020 | -$5.85 | -$7.45 | -$8.25 - -$6.15 | +21.48% | Beat | N/A | 5 | N/A | Aug 6, 2020 | N/A |
| Mar 31, 2020 | -$7.72 | -$7.99 | -$9.90 - -$6.15 | +3.38% | Beat | N/A | 5 | N/A | May 7, 2020 | N/A |
| Dec 31, 2019 | -$9.75 | -$9.14 | -$10.19 - -$7.20 | -6.67% | Miss | N/A | 6 | N/A | Mar 12, 2020 | N/A |
| Sep 30, 2019 | -$10.05 | -$10.01 | -$11.54 - -$7.50 | -0.40% | Miss | N/A | 7 | N/A | Nov 12, 2019 | N/A |
| Jun 30, 2019 | -$11.40 | -$11.59 | -$13.64 - -$8.85 | +1.64% | Beat | N/A | 8 | N/A | Aug 14, 2019 | N/A |
| Mar 31, 2019 | -$12.75 | -$9.48 | -$10.49 - -$8.55 | -34.49% | Miss | N/A | 6 | N/A | May 13, 2019 | N/A |
| Dec 31, 2018 | -$9.60 | -$9.10 | -$9.90 - -$8.25 | -5.49% | Miss | N/A | 7 | N/A | Mar 13, 2019 | N/A |
| Sep 30, 2018 | -$8.25 | -$8.37 | -$8.70 - -$7.95 | +1.43% | Beat | N/A | 7 | N/A | Nov 13, 2018 | N/A |
| Jun 30, 2018 | -$7.80 | -$7.64 | -$7.95 - -$7.35 | -2.09% | Miss | N/A | 4 | N/A | Aug 10, 2018 | N/A |
| Mar 31, 2018 | -$8.10 | -$6.19 | -$7.50 - -$6.15 | -30.86% | Miss | N/A | 3 | N/A | May 10, 2018 | N/A |
| Dec 31, 2017 | -$13.35 | -$8.95 | -$9.60 - -$7.65 | -49.16% | Miss | N/A | 3 | N/A | Jan 29, 2018 | N/A |
| Sep 30, 2017 | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 23, 2017 | N/A |
| Dec 31, 2016 | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2017 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.02, after -$3.04 the year before. It was -$0.14 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.02 | N/A |
| Dec 31, 2024 | -$3.04 | N/A |
| Dec 31, 2023 | -$4.85 | N/A |
| Dec 31, 2022 | -$9.82 | N/A |
| Dec 31, 2021 | -$10.20 | N/A |
| Dec 31, 2020 | -$24.82 | N/A |
| Dec 31, 2019 | -$43.95 | N/A |
| Dec 31, 2018 | -$33.75 | N/A |
| Dec 31, 2017 | -$13.87 | N/A |
| Dec 31, 2016 | -$0.14 | N/A |
Frequently Asked Questions About SLDB
When is Solid Biosciences LLC's next earnings date?
Solid Biosciences LLC's next earnings report is expected for Mar 4, 2027.
Did SLDB beat earnings estimates last quarter?
Yes. Solid Biosciences LLC reported EPS of -$0.36 for the quarter ended Sep 30, 2026, above the -$0.37 estimate, a 2.70% surprise.
What EPS do analysts expect from SLDB next quarter?
The consensus EPS estimate for Solid Biosciences LLC for the quarter ending Dec 31, 2026 is -$0.41 from 16 analysts, with estimates from -$0.51 to -$0.36.
How often does SLDB beat earnings estimates?
Solid Biosciences LLC beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -4.93%.
SLDB pages: Overview, Earnings, Forecast, Financials, Competitors